SGLT2 inhibition in patients with type 2 diabetes and cardiovascular diseases: which are the benefits?
Journal Title: Revista de Medicină Militară - Year 2019, Vol 0, Issue 1
Abstract
Two major trials, EMPA-REG OUTCOME trial (with Empagliflozin) and CANVAS trial (with Canagliflozin) have demonstrated the beneficial effects of SGLT2 inhibitors in patients with type 2 diabetes at risk for heart failure. SGLT2 inhibitors possess a unique pharmacological profile and have shown a significant reduction of hospitalization for heart failure in diabetic patients, immediately after treatment commencement. It seems that their effects are beneficial both in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. SGLT2 inhibitors reduce cardiovascular endpoints in patients with diabetes and high cardiovascular risk, most likely through a reduction of heart failure-related events. Empagliflozin treatment exerts beneficial effects on vascular function and central haemodynamics. Various mechanisms seem to contribute to the beneficial effects of SGLT2 inhibitors in heart failure. Taking into consideration their cardiovascular benefits and the number of ongoing trials with these drugs, there is a possibility to expand their indication to nondiabetic patients with heart failure. This review focuses on the newest insights into the beneficial effects of SGLT2 inhibitors on the cardiovascular system
Authors and Affiliations
Camelia Diaconu, Teodor Salmen, Mihnea A Gaman, Ovidiu Bratu, Dan Mischianu, D Marcu, Andra I Suceveanu, Raluca S. Costache, Anca Pantea Stoian
Keywords
Related Articles
- EP ID EP481269
- DOI -
- Views 92
- Downloads 0
Finite element analysis of a modified short hip endoprosthesis
A finite element simulation of the mechanical static features for a modified short hip endoprosthesis was performed. The corkscrew-like femoral stem was modified introducing more turns of the thread. By such an approach...
Multidisciplinary approach to anemia
Introduction: We present the case of a 65 years- old woman who was admitted with a severe macrocytic anemia Hb= 5.7g/dl and diffuse bone pain. Biologically she has moderate thrombocytopenia 35 000/µl, a hepatic cytolysis...
The use of low-intensity ultrasound system in Orthopedics for treatment of fractures
-
Analysis of risk factors for antipsychotic-resistant schizophrenia in young patients – a retrospective analysis
Treatment resistant schizophrenia (TRS) is a severely disabling disorder, which decreases dramatically the quality of life and overall functionality, while it increases the rate of hospital admissions and overall healthc...
Reconsidering the importance of military medicine at the level of National Ministry of Defenceand into society
-